Pluristem Therapeutics Inc (PSTI.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|45||2017||Chairman of the Board, Chief Executive Officer|
|61||2017||President, Co-Chief Executive Officer, Director|
|49||2017||Chief Financial Officer|
|62||2006||Lead Independent Director|
- BRIEF-Pluristem Therapeutics Says Co Sold Its Entire Holdings In CHA Biotech Co For About $10.5 Mln
- BRIEF-FDA Clears Pluristem’s Expanded Access Program To Initiate Treatments Of Critical Limb Ischemia
- BRIEF-Pluristem enters agreement with Tel Aviv Sourasky Medical Center to conduct phase i/ii trial in steroid-refractory chronic GvHD
- BRIEF-PLURISTEM PRICES PUBLIC OFFERING OF COMMON STOCK ON THE TEL AVIV STOCK EXCHANGE
- BRIEF-Pluristem extends trial for treatment of insufficient hematopoietic recovery